Covid-19 Impact on Global Recombinant DNA (rDNA) Technology Market Size, Status and Forecast 2020-2026

July 2020 | 128 pages | ID: C9085C0DF1B6EN
QYResearch

Abstracts

This report focuses on the global Recombinant DNA (rDNA) Technology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Recombinant DNA (rDNA) Technology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• F. Hoffmann-La Roche Ltd (Genentech, Inc)
• Profacgen
• Amgen Inc
• Novartis AG
• GenScript
• Pfizer Inc
• Novo Nordisk A/S
• Eli Lilly and Company
• Sanofi
• Biocon
• GlaxoSmithKline plc
• New England Biolabs.
• Cibus
• Monsanto Company
• Horizon Discovery Group PLC

Market segment by Component, the product can be split into

• Expression System
• Cloning Vector

Market segment by Application, split into

• Biotechnology and Pharmaceutical Companies
• Academic and Government Research Institutes
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Recombinant DNA (rDNA) Technology status, future forecast, growth opportunity, key market and key players.
• To present the Recombinant DNA (rDNA) Technology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

• To define, describe and forecast the market by component, market and key regions.

In this study, the years considered to estimate the market size of Recombinant DNA (rDNA) Technology are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, component and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Recombinant DNA (rDNA) Technology Revenue
1.4 Covid-19 Implications on Market by Component
  1.4.1 Global Recombinant DNA (rDNA) Technology Market Size Growth Rate by Component: 2020 VS 2026
  1.4.2 Expression System
  1.4.3 Cloning Vector
1.5 Covid-19 Implications on Market by Application
  1.5.1 Global Recombinant DNA (rDNA) Technology Market Share by Application: 2020 VS 2026
  1.5.2 Biotechnology and Pharmaceutical Companies
  1.5.3 Academic and Government Research Institutes
  1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Recombinant DNA (rDNA) Technology Industry Impact
  1.6.1 How the Covid-19 is Affecting the Recombinant DNA (rDNA) Technology Industry
    1.6.1.1 Recombinant DNA (rDNA) Technology Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Recombinant DNA (rDNA) Technology Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Recombinant DNA (rDNA) Technology Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Covid-19 Implications on Global Recombinant DNA (rDNA) Technology Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Recombinant DNA (rDNA) Technology Growth Trends by Regions
  2.2.1 Recombinant DNA (rDNA) Technology Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Recombinant DNA (rDNA) Technology Historic Market Share by Regions (2015-2020)
  2.2.3 Recombinant DNA (rDNA) Technology Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Recombinant DNA (rDNA) Technology Market Growth Strategy
  2.3.6 Primary Interviews with Key Recombinant DNA (rDNA) Technology Players (Opinion Leaders)

3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Recombinant DNA (rDNA) Technology Players by Market Size
  3.1.1 Global Top Recombinant DNA (rDNA) Technology Players by Revenue (2015-2020)
  3.1.2 Global Recombinant DNA (rDNA) Technology Revenue Market Share by Players (2015-2020)
  3.1.3 Global Recombinant DNA (rDNA) Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio
  3.2.1 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Recombinant DNA (rDNA) Technology Revenue in 2019
3.3 Recombinant DNA (rDNA) Technology Key Players Head office and Area Served
3.4 Key Players Recombinant DNA (rDNA) Technology Product Solution and Service
3.5 Date of Enter into Recombinant DNA (rDNA) Technology Market
3.6 Mergers & Acquisitions, Expansion Plans

4 COVID-19 IMPLICATIONS ON MARKET SIZE BY COMPONENT (2015-2026)

4.1 Global Recombinant DNA (rDNA) Technology Historic Market Size by Component (2015-2020)
4.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Component (2021-2026)

5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
5.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Recombinant DNA (rDNA) Technology Market Size (2015-2020)
6.2 Recombinant DNA (rDNA) Technology Key Players in North America (2019-2020)
6.3 North America Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020)
6.4 North America Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Recombinant DNA (rDNA) Technology Market Size (2015-2020)
7.2 Recombinant DNA (rDNA) Technology Key Players in Europe (2019-2020)
7.3 Europe Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020)
7.4 Europe Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)

8 CHINA

8.1 China Recombinant DNA (rDNA) Technology Market Size (2015-2020)
8.2 Recombinant DNA (rDNA) Technology Key Players in China (2019-2020)
8.3 China Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020)
8.4 China Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Recombinant DNA (rDNA) Technology Market Size (2015-2020)
9.2 Recombinant DNA (rDNA) Technology Key Players in Japan (2019-2020)
9.3 Japan Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020)
9.4 Japan Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Recombinant DNA (rDNA) Technology Market Size (2015-2020)
10.2 Recombinant DNA (rDNA) Technology Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Recombinant DNA (rDNA) Technology Market Size by Type (2015-2020)
10.4 Southeast Asia Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)

11 INDIA

11.1 India Recombinant DNA (rDNA) Technology Market Size (2015-2020)
11.2 Recombinant DNA (rDNA) Technology Key Players in India (2019-2020)
11.3 India Recombinant DNA (rDNA) Technology Market Size by Type (2015-2020)
11.4 India Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Recombinant DNA (rDNA) Technology Market Size (2015-2020)
12.2 Recombinant DNA (rDNA) Technology Key Players in Central & South America (2019-2020)
12.3 Central & South America Recombinant DNA (rDNA) Technology Market Size by Type (2015-2020)
12.4 Central & South America Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 F. Hoffmann-La Roche Ltd (Genentech, Inc)
  13.1.1 F. Hoffmann-La Roche Ltd (Genentech, Inc) Company Details
  13.1.2 F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview and Its Total Revenue
  13.1.3 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Introduction
  13.1.4 F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020))
  13.1.5 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Development
13.2 Profacgen
  13.2.1 Profacgen Company Details
  13.2.2 Profacgen Business Overview and Its Total Revenue
  13.2.3 Profacgen Recombinant DNA (rDNA) Technology Introduction
  13.2.4 Profacgen Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
  13.2.5 Profacgen Recent Development
13.3 Amgen Inc
  13.3.1 Amgen Inc Company Details
  13.3.2 Amgen Inc Business Overview and Its Total Revenue
  13.3.3 Amgen Inc Recombinant DNA (rDNA) Technology Introduction
  13.3.4 Amgen Inc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
  13.3.5 Amgen Inc Recent Development
13.4 Novartis AG
  13.4.1 Novartis AG Company Details
  13.4.2 Novartis AG Business Overview and Its Total Revenue
  13.4.3 Novartis AG Recombinant DNA (rDNA) Technology Introduction
  13.4.4 Novartis AG Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
  13.4.5 Novartis AG Recent Development
13.5 GenScript
  13.5.1 GenScript Company Details
  13.5.2 GenScript Business Overview and Its Total Revenue
  13.5.3 GenScript Recombinant DNA (rDNA) Technology Introduction
  13.5.4 GenScript Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
  13.5.5 GenScript Recent Development
13.6 Pfizer Inc
  13.6.1 Pfizer Inc Company Details
  13.6.2 Pfizer Inc Business Overview and Its Total Revenue
  13.6.3 Pfizer Inc Recombinant DNA (rDNA) Technology Introduction
  13.6.4 Pfizer Inc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
  13.6.5 Pfizer Inc Recent Development
13.7 Novo Nordisk A/S
  13.7.1 Novo Nordisk A/S Company Details
  13.7.2 Novo Nordisk A/S Business Overview and Its Total Revenue
  13.7.3 Novo Nordisk A/S Recombinant DNA (rDNA) Technology Introduction
  13.7.4 Novo Nordisk A/S Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
  13.7.5 Novo Nordisk A/S Recent Development
13.8 Eli Lilly and Company
  13.8.1 Eli Lilly and Company Company Details
  13.8.2 Eli Lilly and Company Business Overview and Its Total Revenue
  13.8.3 Eli Lilly and Company Recombinant DNA (rDNA) Technology Introduction
  13.8.4 Eli Lilly and Company Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
  13.8.5 Eli Lilly and Company Recent Development
13.9 Sanofi
  13.9.1 Sanofi Company Details
  13.9.2 Sanofi Business Overview and Its Total Revenue
  13.9.3 Sanofi Recombinant DNA (rDNA) Technology Introduction
  13.9.4 Sanofi Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
  13.9.5 Sanofi Recent Development
13.10 Biocon
  13.10.1 Biocon Company Details
  13.10.2 Biocon Business Overview and Its Total Revenue
  13.10.3 Biocon Recombinant DNA (rDNA) Technology Introduction
  13.10.4 Biocon Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
  13.10.5 Biocon Recent Development
13.11 GlaxoSmithKline plc
  10.11.1 GlaxoSmithKline plc Company Details
  10.11.2 GlaxoSmithKline plc Business Overview and Its Total Revenue
  10.11.3 GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Introduction
  10.11.4 GlaxoSmithKline plc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
  10.11.5 GlaxoSmithKline plc Recent Development
13.12 New England Biolabs.
  10.12.1 New England Biolabs. Company Details
  10.12.2 New England Biolabs. Business Overview and Its Total Revenue
  10.12.3 New England Biolabs. Recombinant DNA (rDNA) Technology Introduction
  10.12.4 New England Biolabs. Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
  10.12.5 New England Biolabs. Recent Development
13.13 Cibus
  10.13.1 Cibus Company Details
  10.13.2 Cibus Business Overview and Its Total Revenue
  10.13.3 Cibus Recombinant DNA (rDNA) Technology Introduction
  10.13.4 Cibus Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
  10.13.5 Cibus Recent Development
13.14 Monsanto Company
  10.14.1 Monsanto Company Company Details
  10.14.2 Monsanto Company Business Overview and Its Total Revenue
  10.14.3 Monsanto Company Recombinant DNA (rDNA) Technology Introduction
  10.14.4 Monsanto Company Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
  10.14.5 Monsanto Company Recent Development
13.15 Horizon Discovery Group PLC
  10.15.1 Horizon Discovery Group PLC Company Details
  10.15.2 Horizon Discovery Group PLC Business Overview and Its Total Revenue
  10.15.3 Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Introduction
  10.15.4 Horizon Discovery Group PLC Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
  10.15.5 Horizon Discovery Group PLC Recent Development

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Recombinant DNA (rDNA) Technology Key Market Segments
Table 2. Key Players Covered: Ranking by Recombinant DNA (rDNA) Technology Revenue
Table 3. Ranking of Global Top Recombinant DNA (rDNA) Technology Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Recombinant DNA (rDNA) Technology Market Size Growth Rate by Component (US$ Million): 2020 VS 2026
Table 5. Key Players of Expression System
Table 6. Key Players of Cloning Vector
Table 7. COVID-19 Impact Global Market: (Four Recombinant DNA (rDNA) Technology Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Recombinant DNA (rDNA) Technology Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Recombinant DNA (rDNA) Technology Players to Combat Covid-19 Impact
Table 12. Global Recombinant DNA (rDNA) Technology Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Recombinant DNA (rDNA) Technology Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Recombinant DNA (rDNA) Technology Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Recombinant DNA (rDNA) Technology Market Share by Regions (2015-2020)
Table 16. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Recombinant DNA (rDNA) Technology Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Recombinant DNA (rDNA) Technology Market Growth Strategy
Table 22. Main Points Interviewed from Key Recombinant DNA (rDNA) Technology Players
Table 23. Global Recombinant DNA (rDNA) Technology Revenue by Players (2015-2020) (Million US$)
Table 24. Global Recombinant DNA (rDNA) Technology Market Share by Players (2015-2020)
Table 25. Global Top Recombinant DNA (rDNA) Technology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant DNA (rDNA) Technology as of 2019)
Table 26. Global Recombinant DNA (rDNA) Technology by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Recombinant DNA (rDNA) Technology Product Solution and Service
Table 29. Date of Enter into Recombinant DNA (rDNA) Technology Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020) (Million US$)
Table 32. Global Recombinant DNA (rDNA) Technology Market Size Share by Component (2015-2020)
Table 33. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Component (2021-2026)
Table 34. Global Recombinant DNA (rDNA) Technology Market Size Share by Application (2015-2020)
Table 35. Global Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) (Million US$)
Table 36. Global Recombinant DNA (rDNA) Technology Market Size Share by Application (2021-2026)
Table 37. North America Key Players Recombinant DNA (rDNA) Technology Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Recombinant DNA (rDNA) Technology Market Share (2019-2020)
Table 39. North America Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020) (Million US$)
Table 40. North America Recombinant DNA (rDNA) Technology Market Share by Component (2015-2020)
Table 41. North America Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) (Million US$)
Table 42. North America Recombinant DNA (rDNA) Technology Market Share by Application (2015-2020)
Table 43. Europe Key Players Recombinant DNA (rDNA) Technology Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Recombinant DNA (rDNA) Technology Market Share (2019-2020)
Table 45. Europe Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020) (Million US$)
Table 46. Europe Recombinant DNA (rDNA) Technology Market Share by Component (2015-2020)
Table 47. Europe Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Recombinant DNA (rDNA) Technology Market Share by Application (2015-2020)
Table 49. China Key Players Recombinant DNA (rDNA) Technology Revenue (2019-2020) (Million US$)
Table 50. China Key Players Recombinant DNA (rDNA) Technology Market Share (2019-2020)
Table 51. China Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020) (Million US$)
Table 52. China Recombinant DNA (rDNA) Technology Market Share by Component (2015-2020)
Table 53. China Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) (Million US$)
Table 54. China Recombinant DNA (rDNA) Technology Market Share by Application (2015-2020)
Table 55. Japan Key Players Recombinant DNA (rDNA) Technology Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Recombinant DNA (rDNA) Technology Market Share (2019-2020)
Table 57. Japan Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020) (Million US$)
Table 58. Japan Recombinant DNA (rDNA) Technology Market Share by Component (2015-2020)
Table 59. Japan Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Recombinant DNA (rDNA) Technology Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Recombinant DNA (rDNA) Technology Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Recombinant DNA (rDNA) Technology Market Share (2019-2020)
Table 63. Southeast Asia Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020) (Million US$)
Table 64. Southeast Asia Recombinant DNA (rDNA) Technology Market Share by Component (2015-2020)
Table 65. Southeast Asia Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Recombinant DNA (rDNA) Technology Market Share by Application (2015-2020)
Table 67. India Key Players Recombinant DNA (rDNA) Technology Revenue (2019-2020) (Million US$)
Table 68. India Key Players Recombinant DNA (rDNA) Technology Market Share (2019-2020)
Table 69. India Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020) (Million US$)
Table 70. India Recombinant DNA (rDNA) Technology Market Share by Component (2015-2020)
Table 71. India Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) (Million US$)
Table 72. India Recombinant DNA (rDNA) Technology Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Recombinant DNA (rDNA) Technology Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Recombinant DNA (rDNA) Technology Market Share (2019-2020)
Table 75. Central & South America Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020) (Million US$)
Table 76. Central & South America Recombinant DNA (rDNA) Technology Market Share by Component (2015-2020)
Table 77. Central & South America Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Recombinant DNA (rDNA) Technology Market Share by Application (2015-2020)
Table 79. F. Hoffmann-La Roche Ltd (Genentech, Inc) Company Details
Table 80. F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview
Table 81. F. Hoffmann-La Roche Ltd (Genentech, Inc) Product
Table 82. F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 83. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Development
Table 84. Profacgen Company Details
Table 85. Profacgen Business Overview
Table 86. Profacgen Product
Table 87. Profacgen Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 88. Profacgen Recent Development
Table 89. Amgen Inc Company Details
Table 90. Amgen Inc Business Overview
Table 91. Amgen Inc Product
Table 92. Amgen Inc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 93. Amgen Inc Recent Development
Table 94. Novartis AG Company Details
Table 95. Novartis AG Business Overview
Table 96. Novartis AG Product
Table 97. Novartis AG Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 98. Novartis AG Recent Development
Table 99. GenScript Company Details
Table 100. GenScript Business Overview
Table 101. GenScript Product
Table 102. GenScript Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 103. GenScript Recent Development
Table 104. Pfizer Inc Company Details
Table 105. Pfizer Inc Business Overview
Table 106. Pfizer Inc Product
Table 107. Pfizer Inc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 108. Pfizer Inc Recent Development
Table 109. Novo Nordisk A/S Company Details
Table 110. Novo Nordisk A/S Business Overview
Table 111. Novo Nordisk A/S Product
Table 112. Novo Nordisk A/S Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 113. Novo Nordisk A/S Recent Development
Table 114. Eli Lilly and Company Business Overview
Table 115. Eli Lilly and Company Product
Table 116. Eli Lilly and Company Company Details
Table 117. Eli Lilly and Company Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 118. Eli Lilly and Company Recent Development
Table 119. Sanofi Company Details
Table 120. Sanofi Business Overview
Table 121. Sanofi Product
Table 122. Sanofi Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 123. Sanofi Recent Development
Table 124. Biocon Company Details
Table 125. Biocon Business Overview
Table 126. Biocon Product
Table 127. Biocon Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 128. Biocon Recent Development
Table 129. GlaxoSmithKline plc Company Details
Table 130. GlaxoSmithKline plc Business Overview
Table 131. GlaxoSmithKline plc Product
Table 132. GlaxoSmithKline plc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 133. GlaxoSmithKline plc Recent Development
Table 134. New England Biolabs. Company Details
Table 135. New England Biolabs. Business Overview
Table 136. New England Biolabs. Product
Table 137. New England Biolabs. Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 138. New England Biolabs. Recent Development
Table 139. Cibus Company Details
Table 140. Cibus Business Overview
Table 141. Cibus Product
Table 142. Cibus Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 143. Cibus Recent Development
Table 144. Monsanto Company Company Details
Table 145. Monsanto Company Business Overview
Table 146. Monsanto Company Product
Table 147. Monsanto Company Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 148. Monsanto Company Recent Development
Table 149. Horizon Discovery Group PLC Company Details
Table 150. Horizon Discovery Group PLC Business Overview
Table 151. Horizon Discovery Group PLC Product
Table 152. Horizon Discovery Group PLC Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 153. Horizon Discovery Group PLC Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Recombinant DNA (rDNA) Technology Market Share by Component: 2020 VS 2026
Figure 2. Expression System Features
Figure 3. Cloning Vector Features
Figure 4. Global Recombinant DNA (rDNA) Technology Market Share by Application: 2020 VS 2026
Figure 5. Biotechnology and Pharmaceutical Companies Case Studies
Figure 6. Academic and Government Research Institutes Case Studies
Figure 7. Other Case Studies
Figure 8. Recombinant DNA (rDNA) Technology Report Years Considered
Figure 9. Global Recombinant DNA (rDNA) Technology Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Recombinant DNA (rDNA) Technology Market Share by Regions: 2020 VS 2026
Figure 11. Global Recombinant DNA (rDNA) Technology Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Recombinant DNA (rDNA) Technology Market Share by Players in 2019
Figure 14. Global Top Recombinant DNA (rDNA) Technology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant DNA (rDNA) Technology as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Recombinant DNA (rDNA) Technology Revenue in 2019
Figure 16. North America Recombinant DNA (rDNA) Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Recombinant DNA (rDNA) Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Recombinant DNA (rDNA) Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Recombinant DNA (rDNA) Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Recombinant DNA (rDNA) Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Recombinant DNA (rDNA) Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. F. Hoffmann-La Roche Ltd (Genentech, Inc) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 25. Profacgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Profacgen Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 27. Amgen Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Amgen Inc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 29. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Novartis AG Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 31. GenScript Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. GenScript Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 33. Pfizer Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Pfizer Inc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 35. Novo Nordisk A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Novo Nordisk A/S Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 37. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Eli Lilly and Company Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 39. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Sanofi Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 41. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Biocon Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 43. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. GlaxoSmithKline plc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 45. New England Biolabs. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. New England Biolabs. Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 47. Cibus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Cibus Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 49. Monsanto Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Monsanto Company Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 51. Horizon Discovery Group PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Horizon Discovery Group PLC Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed